Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn's disease: a KASID prospective multicenter study (vol 21, pg 137, 2023)

被引：0
|
作者：
Oh, Kyunghwan [1 ]
Hong, Hee Seung [1 ]
Ham, Nam Seok [1 ]
Lee, Jungbok [2 ]
Park, Sang Hyoung [1 ,3 ,4 ]
Yang, Suk-Kyun [1 ,3 ,4 ]
Yoon, Hyuk [5 ]
Kim, You Sun [6 ]
Choi, Chang Hwan [7 ]
Ye, Byong Duk [1 ,3 ,4 ]
机构：
[1] Univ Ulsan, Asan Med Ctr, Dept Gastroenterol, Coll Med, Seoul, South Korea
[2] Univ Ulsan, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Coll Med, Seoul, South Korea
[3] Univ Ulsan, Inflammatory Bowel Dis Ctr, Asan Med Ctr, Coll Med, Seoul, South Korea
[4] Univ Ulsan, Digest Dis Res Ctr, Coll Med, Seoul, South Korea
[5] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea
[6] Inje Univ, Seoul Paik Hosp, Dept Internal Med, Coll Med, Seoul, South Korea
[7] Chung Ang Univ, Dept Internal Med, Coll Med, Seoul, South Korea
来源：
INTESTINAL RESEARCH | 2023年 / 21卷 / 02期
关键词：
D O I：
10.5217/ir.2021.00173.e
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [31] Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidence
    Engel, Tal
    Yung, Diana E.
    Ma, Christopher
    Pariente, Benjamin
    Wils, Pauline
    Eliakim, Rami
    Ungar, Bella
    Ben-Horin, Shomron
    Kopylov, Uri
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (09) : 1232 - 1240
  • [32] MULTICENTER REAL-WORLD EXPERIENCE OF USTEKINUMAB TROUGH LEVELS AND ANTIBODIES IN CROHN'S DISEASE MAINTENANCE THERAPY
    Ramos, Guilherme Piovezani
    Tharayil, Vivek
    Kurdi, Ahmed T.
    Bali, Aman S.
    Rolak, Stacey C.
    Fredrick, Thomas W.
    Neto, Manuel B. Braga
    Vinsard, Daniela Guerrero
    Urquhart, Siri A.
    Dunleavy, Katie A.
    Bakhshi, Zeinab
    Tariq, Raseen
    Becker, Michelle
    Johnson, Amanda M.
    Pasha, Shabana F.
    Hashash, Jana G.
    Harmsen, William S.
    Willrich, Maria Alice V.
    Loftus, Edward V.
    GASTROENTEROLOGY, 2022, 162 (07) : S802 - S802
  • [33] Long-Term Effectiveness and Safety of Ustekinumab for The Treatment of Crohn′s Disease: A Brazilian Multicentre Real-world Study
    Oleg, Knyazev
    Albina, Lishchinskaya
    Anatoliy, Konoplyannikov
    Anna, Kagramanova
    Nina, Fadeeva
    Dmitriy, Kulakov
    Anait, Babayan
    Mariya, Zvyaglova
    Asfold, Parfenov
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S2 - S2
  • [34] Real-world effectiveness and safety of Risankizumab in Crohn's Disease
    Mcshane, C.
    Olivera Sendra, P. A.
    Kim, J.
    Milgrom, R.
    Stempak, J.
    Nguyen, G.
    Weizman, A., V
    Croitoru, K.
    Gallinger, Z.
    Huang, V
    Steinhart, H.
    Targownik, L.
    Lee, S. H.
    Silverberg, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I2023 - I2024
  • [35] EFFICACY AND SAFETY OF USTEKINUMAB IN CROHN'S DISEASE: A REAL-WORLD STUDY FROM THE WEST MIDLANDS
    Mozdiak, Ella
    Aleem, Muhammad Junaid
    Alhamamy, Noor
    Kalkat, Harkaran
    Port, Saskia
    Rupra, Roshan
    Sharma, Naveen
    Monga, Muhammad Ali
    Andrew, Mark
    GUT, 2021, 70 : A109 - A110
  • [36] Real-world effectiveness and safety of vedolizumab induction therapy for Crohn's disease in Poland - a prospective, observational POLONEZ II study considering patients reported outcomes.
    Liebert, A.
    Klopocka, M.
    Cichoz-Lach, H.
    Michalak, A.
    Talar-Wojnarowska, R.
    Domzal-Magrowska, D.
    Filipiuk, A.
    Krogulecki, M.
    Kopertowska-Majchrzak, M.
    Eder, P.
    Stawczyk-Eder, K.
    Waszak, K.
    Zagorowicz, E.
    Wojciechowski, K.
    Drygala, S.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 550 - 551
  • [37] Real-world effectiveness of upadacitinib induction therapy in Crohn's disease, with a focus on patients with concomitant IMIDs
    Gonzalez, A. Elosua
    Zabalza, L.
    Vicuna, M.
    Rubio, S.
    Nantes, O.
    Rodriguez, C.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1840 - i1840
  • [38] Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
    Amiot, Aurelien
    Filippi, Jerome
    Abitbol, Vered
    Cadiot, Guillaume
    Laharie, David
    Serrero, Melanie
    Altwegg, Romain
    Bouhnik, Yoram
    Peyrin-Biroulet, Laurent
    Gilletta, Cyrielle
    Roblin, Xavier
    de Chambrun, Guillaume Pineton
    Vuitton, Lucine
    Bourrier, Anne
    Nancey, Stephane
    Gornet, Jean-Marc
    Nahon, Stephane
    Bouguen, Guillaume
    Viennot, Stephanie
    Pariente, Benjamin
    Fumery, Mathurin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (11) : 1039 - 1046
  • [39] Systematic Review and Meta-analysis Evaluating the Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease
    Hosack, T.
    Gadhok, R.
    Lindsay, J. O.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I523 - I523
  • [40] Systematic Review and Meta-analysis Evaluating the Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease
    Hosack, T.
    Gadhok, R.
    Lindsay, J. O.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I523 - I523
12345